Roger A Milam
Biographic Data
| ID | 5545963 |
|---|---|
| NAME | Roger A Milam |
| GIVEN NAMES | Roger A |
| FAMILY NAME | Milam |
| SIGNATURE | MILAM R A |
| AFFILIATIONS | Centers for Medicare and Medicaid Services |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1994 |
| LATEST PUBLICATION YEAR | 1994 |
| H-INDEX | 0 |
The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients
Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…
No prominent works on this page.
The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients
Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administrat…
Business (1 work) · Dialysis and Renal Disease Management (1 work) · Dosing (1 work) · Erythropoietin (1 work) · Finance (1 work) · Finance (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Healthcare Policy and Management (1 work) · Internal Medicine (1 work) · Internal Medicine (1 work)